Latest filing published 14 Jun 2022 for LifeStance Health Group, Inc., €449k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gwen H. Booth: trading record in brief
Gwen H. Booth (senior executive) discloses dealings in LifeStance Health Group, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 25 April 2022 to 13 June 2022.
Every open-market trade on record is a sale: 1 sale worth €449k. Other entries cover 1 share grant.
On 14 June 2022 came the latest disclosure, an open-market sale for €449k in LifeStance Health Group, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gwen H. Booth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 88,798 shares@ US$5.27100.0% of flowCommon StockSEC:0000899243-22-022395:0
- 76,457 shares0Common StockSEC:0000899243-22-015681:0
2 of 2 declarations
